Clinical Trial Details

Trial ID: L0820
Source ID: IRCT201705016312N4
Associated Drug: Vitamin E
Title: Effect of Vitamin E and Pioglitazone in patients with non-alcoholic fatty liver disease in Marvdasht Hospital
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Non-alcoholic fatty liver. <br>Nonalcoholic steatohepatitis;Nonalcoholic steatohepatitis
Interventions: Intervention 1: Intervention group: lifestyle modification and Vitamin E 400IU/day for 3 months. Intervention 2: Intervention group: lifestyle modification and pioglitazone 15 mg/day for 3 months. Intervention 3: Control group: lifestyle modification and
Outcome Measures: Liver function test. Timepoint: Before intervention - 3 months after intervention. Method of measurement: ELISA.Body Mass Index. Timepoint: Before intervention - 3 months after intervention. Method of measurement: By BMI Formula.
Sponsor/Collaborators: Vice chancellor for research, Shiraz University Of Medical Science
Gender: All
Age: 18 years60 years
Phases: Not applicable
Enrollment: 90
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 20/05/2017
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/6761